Med-El Acquires Two Gene Therapy Programs from Rescue Hearing
Med-El has acquired two gene therapy programs from Rescue Hearing Inc targeting mutations in the MYO7A and STRC genes, expanding the hearing implant company's pipeline into biological approaches to vestibular and auditory dysfunction.